Skip to main content
Caplight Logo









Essenvia

Essenvia

Private
Los Angeles, CaliforniaEnterprise Softwarehttps://essenvia.com/

Last Round

Series A

Nov 15, 2023

Total Funding Raised

$4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Essenvia is a health-tech company that provides an AI-powered regulatory information management platform to streamline medical device regulatory submissions and lifecycle management.

Sector

Enterprise Software

Verticals

Medical Devices, RegTech, Compliance, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

regulatory information managementRIMMedTech complianceRegTechregulatory submission softwaremedical device regulationeSTARFDA submissionAI-native SaaSregulatory workflow automationregulatory intelligencecompliance automationsubmission AIregulatory opsvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Essenvia Comparables

Compare Essenvia with similar companies based on industry and business-model similarity.

Essenvia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rimsys
93%
RegDesk
84%
Cruxi
83%

Essenvia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 15, 2023
SeedMay 2, 2023

Key People

Founding team and executive leadership

Soumya Mahapatra

Founder & CEO

Founding Team

Essenvia Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 69% MoM, reaching 3.8K.

  • Nov 7, 2025

    Monthly visitors increased 130% MoM, reaching 3.3K.

Essenvia Filings

Explore SEC and related filing metadata, where available.

Essenvia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Essenvia's valuation, stock price, and market status.

Is Essenvia a public or private company?

Essenvia is a private company.

What is the current stock price of Essenvia?

Essenvia is a private company with no public stock price. No recent secondary market data is available.

How much is Essenvia worth (valuation)?

Valuation information for Essenvia is not publicly available.

Can I buy Essenvia stock?

Essenvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Essenvia's last funding round?

Essenvia's most recent funding round was Series A on November 15, 2023.

Who are the main investors in Essenvia?

Key investors in Essenvia include Wavemaker Three-Sixty Health, Benhamou Global Ventures.

Will Essenvia IPO soon?

No public IPO plans have been announced for Essenvia.

How can I track Essenvia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Essenvia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range16
Year Founded2018
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?